Jeffrey M. Benzick, MD Adult Psychiatry San Antonio, TX
Jeffrey M. Benzick, MDAdult PsychiatrySan Antonio, TX

Jeffrey M. Benzick, MD, PA

14800 San Pedro Ave

Suite 110

San Antonio, TX 78232


210 490-9850 Phone

210 490-1465 Fax


Please call us to set up your appointment. 



Office Hours

We are open during the following hours:


Monday-Thursday 8:15 AM to 4:45 PM

Friday 8:15 AM to 12 Noon


I stay after hours most Fridays to accommodate patient schedules.  I also work two Saturdays a month.  Please feel free to call if these better meet your needs.


Connect With Us

Policy on Anxiety (benzodiazepine) and Sleep (Z-drug) Medications

Evolving research and heightened scrutiny of quality of care—along with law enforcement concerns of misuse and diversion—have intensified the concern and monitoring long term (and even short term) benzodiazepine use.


Therefore, this compels an update of my practice policies, especially for those persons taking long term benzodiazepines with no obvious side effects or complications. (The operative word is “obvious.”) In short, the mere fact of long term usage requires careful scrutiny.


Because tranquilizers in the Z-class (Ambien, Sonata, Lunesta) and benzodiazepine class such as Xanax (alprazolam), Ativan (lorazepam) Klonopin (clonazepam), Valium (diazepam), Restoril (temazepam) and others are controlled substances subject to definite standards of clinical and ethical care — as well as laws— prescription policy for such in this practice bears reiteration. Their risks are well known, including—but not limited to — dependency, addiction, impaired alertness and coordination (i.e. people are more likely to fall when taking them), and illegal misuse and diversion. They can be especially problematic when combined with legitimate medications, and/or ill-advised medicines referred to below. Furthermore, because they are widespread and easy to find in the community, they may be diverted and frequently present in the mix of narcotic overdose. For some public health and law enforcement agencies, this approaches a public health hazard.


These tranquilizing medications, when used only as prescribed, are very effective agents for the immediate relief of acute anxiety. They are indicated (short term) in appropriate clinical situations, as long as there are no contraindications. Those contraindications would include—but not be limited to—past or current misuse of benzodiazepines and other dependency-producing substances such as alcohol, cannabis, narcotic pain meds, stimulants, barbiturates, and various street drugs. Also, any history of illegal activity (convicted or not) connected with use of such.


Therefore, benzodiazepines are prescribed for acute use (assuming no contraindications) for up to 3 months. Chronic maintenance is rarely supported, even for those whose lives seem continually fraught with life’s stress. Again, at best, they are to be used only as needed. Clinical research has shown that tolerance develops over time with these medications, making them no longer effective at the accustomed dose. However, many patients consider them necessary because abrupt attempts to stop are met with anxiety symptoms. Reasons could be many:

  • Most common are withdrawal symptoms.
  • Inadequate accepted treatment of ongoing biological anxiety disorder (such as General Anxiety Disorder (GAD), Social Anxiety Disorder (SAD), Obsessive Compulsive Disorder (OCD) and Panic Disorder (PD)
  • Psychological craving, reliance, or looking for placebo response.

For those who have been taking benzodiazepines long term, abruptly stopping could quickly lead to un- comfortable and even dangerous withdrawal symptoms. Therefore, a gradual taper schedule is called for in order to achieve physiological freedom from the tranquilizer. The time required can be individualized, and, as many of us have already discussed, will occur over several months if not years.


If more time, or closer monitoring, be required at any time, a formal outpatient detox program would be in order. If this proves too limiting and/or challenging, inpatient detox might be necessary.

For those who for years have been incorporating benzodiazepines into their very coping, the “loss” of such medication can seem daunting. In such instances—be they outpatient or inpatient—stress management counseling, especially CBT or neurofeedback training, could support the detox and shift to alternatives with a suitable practitioner.  I am always pleased to meet and discuss with you alternative therapies, be they pharmacologic, psychotherapeutic, CBT, neurofeedback, meditation, prayer, exercise and the like.  Additionally, I am committed to learning new research in functional/integrative treatment such as nutritional and supplement interventions.


For most people in this practice, benzodiazepine use (problematic or not) is only a relatively minor aspect of their medication protocol. Their more important medications pertain to mood, anxiety, adjustment and attention disorders. Getting off the “benzo” (and any other uncalled-for substance) will only enhance the treatment of all conditions and improve quality of life.


Please bear in mind that the fact of (strictly) adhering to a long term benzo prescription in and of itself does not necessarily justify continued use month after month, year after year. (That especially includes those who want only benzo prescriptions.) The same goes for those looking for symptomatic relief from seemingly relentless stress. In effect, the benzo replaces healthy coping. Subtle side effects of such are now acknowledged so that the cost/benefit assessment is warranted.


Thank you for reading this reminder—and update. I look forward to reviewing your protocol with you so that we can answer questions and make any required changes.  If you would like to see the research on the topic, I will direct you to this link: The Kaiser Permanente group put together a very well written summary for healthcare professionals with a detailed bibliography.




Print Print | Sitemap
© Jeffrey M. Benzick, MD, PA